Science Johns Hopkins researchers recommend reclassifying magic mushrooms from schedule I to IV drug David Pescovitz
lsd Psychedelic pharmaceutical company asks FDA for permission to conduct LSD therapy Mark Frauenfelder
drugs Oakland, California decriminalized shrooms, peyote, and other psychoactive plants and fungi David Pescovitz
Science Trials confirm the use of psilocybin for depression without the "dulling" effects of traditional antidepressants Cory Doctorow